Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype.

Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype.

AIMS/HYPOTHESIS: Heterozygous activating mutations in KCNJ11, which encodes the Kir6.2 subunit of the pancreatic ATP-sensitive potassium (K(ATP)) channel, cause both permanent and transient neonatal diabetes. A minority of patients also have neurological features. The identification of a KCNJ11 muta...

Full description

Bibliographic Details
Main Authors:	Flanagan, SE, Edghill, E, Gloyn, A, Ellard, S, Hattersley, A
Format:	Journal article
Language:	English
Published:	2006

Similar Items

Activating mutations in the KCNJ11 gene encoding the ATP-sensitive K+ channel subunit Kir6.2 are rare in clinically defined type 1 diabetes diagnosed before 2 years.
by: Edghill, E, et al.
Published: (2004)

An in-frame deletion in Kir6.2 (KCNJ11) causing neonatal diabetes reveals a site of interaction between Kir6.2 and SUR1.
by: Craig, T, et al.
Published: (2009)

Permanent neonatal diabetes due to paternal germline mosaicism for an activating mutation of the KCNJ11 Gene encoding the Kir6.2 subunit of the beta-cell potassium adenosine triphosphate channel.
by: Gloyn, A, et al.
Published: (2004)

Mutations in the genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) in diabetes mellitus and hyperinsulinism.
by: Gloyn, A, et al.
Published: (2006)

Update of mutations in the genes encoding the pancreatic beta-cell K(ATP) channel subunits Kir6.2 (KCNJ11) and sulfonylurea receptor 1 (ABCC8) in diabetes mellitus and hyperinsulinism.
by: Flanagan, SE, et al.
Published: (2009)

Neonatal diabetes - The role of KCNJ11 (Kir6.2)
by: Tammaro, P
Published: (2007)

Functional analysis of two Kir6.2 (KCNJ11) mutations, K170T and E322K, causing neonatal diabetes.
by: Tarasov, A, et al.
Published: (2007)

Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy.
by: Sagen, J, et al.
Published: (2004)

Permanent neonatal diabetes caused by an in-frame deletion in the N-terminus of Kir6.2
by: Craig, T, et al.
Published: (2008)

Interaction between mutations in the slide helix of Kir6.2 associated with neonatal diabetes and neurological symptoms.
by: Männikkö, R, et al.
Published: (2010)

Mutations at the same residue (R50) of Kir6.2 (KCNJ11) that cause neonatal diabetes produce different functional effects.
by: Shimomura, K, et al.
Published: (2006)

Functional analysis of six Kir6.2 (KCNJ11) mutations causing neonatal diabetes.
by: Girard, C, et al.
Published: (2006)

Origin of de novo KCNJ11 mutations and risk of neonatal diabetes for subsequent siblings.
by: Edghill, E, et al.
Published: (2007)

Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes.
by: Gloyn, A, et al.
Published: (2004)

Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes.
by: Gloyn, A, et al.
Published: (2003)

Adjacent mutations in the gating loop of Kir6.2 produce neonatal diabetes and hyperinsulinism.
by: Shimomura, K, et al.
Published: (2009)

Large-scale association studies of variants in genes encoding the pancreatic beta-cell K-ATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes
by: Gloyn, A, et al.
Published: (2003)

Glimepiride block of Kir6.2/SUR1 Kir6.2/SUR2A and Kir6.2/SUR2A and Kir6.2/SUR2B K-ATP channels.
by: Ashcroft, F, et al.
Published: (2001)

Quantitative traits associated with the Type 2 diabetes susceptibility allele in Kir6.2.
by: Weedon, M, et al.
Published: (2003)

A Kir6.2 mutation causing severe functional effects in vitro produces neonatal diabetes without the expected neurological complications.
by: Tammaro, P, et al.
Published: (2008)

Molecular basis of Kir6.2 mutations causing neonatal diabetes and neonatal diabetes with neurological features
by: Proks, P, et al.
Published: (2005)

A gating mutation at the internal mouth of the Kir6.2 pore is associated with DEND syndrome.
by: Proks, P, et al.
Published: (2005)

Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations.
by: Pearson, E, et al.
Published: (2006)

Molecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological features.
by: Proks, P, et al.
Published: (2004)

Effects of mitiglinide (S 21403) on Kir6.2/SUR1, Kir6.2/SUR2A and Kir6.2/SUR2B types of ATP-sensitive potassium channel.
by: Reimann, F, et al.
Published: (2001)

Kir6.2 mutations causing neonatal diabetes provide new insights into Kir6.2-SUR1 interactions.
by: Tammaro, P, et al.
Published: (2005)

The first clinical case of a mutation at residue K185 of Kir6.2 (KCNJ11): a major ATP-binding residue.
by: Shimomura, K, et al.
Published: (2010)

PPARG P12A,Kir6.2/KCNJ11 E23K and early growth in the Northern Finland Birth Cohort of 1966
by: Bennett, A, et al.
Published: (2005)

Functional effects of mutations at F35 in the NH2-terminus of Kir6.2 (KCNJ11), causing neonatal diabetes, and response to sulfonylurea therapy.
by: Proks, P, et al.
Published: (2006)

Characterization of a novel variant in KCNJ16, encoding Kir5.1 channel
by: Biyang Xu, et al.
Published: (2024-10-01)

Time-dependent activation of Kir6.2/SUR2A channels but not Kir6.2/SUR1 channels in the presence of ATP
by: Ashcroft, F, et al.
Published: (2001)

Kir6.2 mutations are a common cause of permanent neonatal diabetes in a large cohort of French patients.
by: Vaxillaire, M, et al.
Published: (2004)

Time-dependent activation of KIR6.2/SUR2A channels but not KIR6.2/SUR1 channels in the presence of MgATP
by: Song, D, et al.
Published: (2001)

Phentolamine block of KATP channels is mediated by Kir6.2.
by: Proks, P, et al.
Published: (1997)

Mapping the architecture of the ATP-binding site of Kir6.2
by: Dabrowski, M, et al.
Published: (2002)

KCNJ11 activating mutations are associated with developmental delay, epilepsy and neonatal diabetes syndrome and other neurological features.
by: Gloyn, A, et al.
Published: (2006)

The value of in vitro studies in a case of neonatal diabetes with a novel Kir6.2-W68G mutation
by: O'Connell, S, et al.
Published: (2015)

Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy.
by: Hattersley, A, et al.
Published: (2005)

A conserved tryptophan at the membrane-water interface acts as a gatekeeper for Kir6.2/SUR1 channels and causes neonatal diabetes when mutated.
by: Männikkö, R, et al.
Published: (2011)

Behavioral phenotyping of mice lacking the K ATP channel subunit Kir6.2.
by: Deacon, R, et al.
Published: (2006)